Poland· PL-100313279
Prialt
A ziconotide product containing ziconotidum, registered in Poland by Esteve Pharmaceuticals GmbH. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ziconotide is registered in 12 of 19 countries.
Countries holding a registration under ATC N02BG08 (ziconotide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Ziconotide · ATC N02BG08
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Ziconotidum
- Manufacturer
- Esteve Pharmaceuticals GmbH
- Country
- Poland (PL)
- ATC code
- N02BG08
- ATC class
- Ziconotide
- Defined daily dose
- 12 mcg, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin04260056117091
- gtin04260056117084
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
59 interactions on record for ziconotide.
Graded by severity as the source publishes them — 59 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ziconotide · interactions on record
59 records
- 59 moderate
Most severe, free to view
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ziconotide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandPrialt 100 ug/ml, InfusionslösungCPS Cito Pharma Services GmbH
- CzechiaPRIALTESTEVE Pharmaceuticals GmbH, Berlín
- SpainPRIALT 100 MICROGRAMOS/ML SOLUCION PARA PERFUSIONEsteve Pharmaceuticals Gmbh
- NorwayPrialtEsteve Pharmaceuticals GmbH
- NetherlandsPrialt 100 microgram/ml, oplossing voor infusieRiemser Pharma GmbH
- SwedenPrialt 100 mikrogram/ml Infusionsvätska, lösningEsteve Pharmaceuticals GmbH
- United KingdomPrialt 100micrograms/1ml solution for infusion vialsEsteve Pharmaceuticals Ltd
- IrelandPRIALTEsteve Pharmaceuticals GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71c30a46-b5f7-45ee-a31e-9f985ea4c31f GET /v1/drugs/71c30a46-b5f7-45ee-a31e-9f985ea4c31f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "100 mcg/ml",
"packaging": "04260056117084 ¦ Rpz ¦ EU/1/04/302/001 ¦ 90375\n1 fiol. 1 ml\n¦ UR/Z/4c/026/24 - 04260056117084 ¦ UR/Z/4c/180/22 - 04260056117084 ¦ UR/Z/4c/025/22 - 04260056117084 ¦ UR/Z/4c/037/25 - 04260056117084\nRpz ¦ EU/1/04/302/002 ¦ 90376\n1 fiol. 2 ml\n04260056117091 ¦ Rpz ¦ EU/1/04/302/003 ¦ 90377\n1 fiol. 5 ml\n¦ UR/Z/4c/104/24 - 04260056117091 ¦ UR/Z/4c/026/22 - 04260056117091 ¦ UR/Z/4c/005/25 - 04260056117091 ¦ UR/Z/4c/027/24 - 04260056117091 ¦ UR/Z/4c/174/25 - 04260056117091 ¦ UR/Z/4c/179/25 - 04260056117091",
"substance": null,
"common_name": "Ziconotidum",
"pl_product_id": "100313279",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about ziconotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.